Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection.
about
Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infectionNovel regimens identified in mice for treatment of latent tuberculosis infection in contacts of patients with multidrug-resistant tuberculosisCharacterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant TuberculosisAnimals devoid of pulmonary system as infection models in the study of lung bacterial pathogensA novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections.An update on the use of rifapentine for tuberculosis therapy.Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosisRecent developments in the epidemiology and management of tuberculosis - new solutions to old problems?Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosisEvaluation of immigrant tuberculosis screening in industrialized countries.Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis InfectionModel-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis.Update in tuberculosis and nontuberculous mycobacterial disease 2011.Bedaquiline for the treatment of drug-resistant tuberculosis.Nonclinical models for antituberculosis drug development: a landscape analysis.Assessment of bactericidal drug activity and treatment outcome in a mouse tuberculosis model using a clinical Beijing strain.After 40 years, new medicine for combating TB.
P2860
Q26824413-C9374DF8-30A7-4EB1-BB8E-C0A100E350BBQ28537749-112060F2-5CA4-4CD5-9A39-6C32209980F9Q33623003-F3F8A2FC-217B-4A74-B5E2-DA72846345E5Q33826578-97A88A2E-482C-4148-AACC-7E3C1577B49EQ33939074-8630AF1B-471E-41AD-8B18-FF1FDEB4A88DQ35048029-41A15CA3-50D5-4811-AFDC-6FA0FA9922CFQ35076966-16E3FE71-10C2-47CD-87B1-BFD1B596EA6CQ35084363-F5C0F18F-D642-4F8E-9204-6EC88AFB6FF0Q35598474-A11E7BCC-F89D-4345-BC40-5BF6C00264EDQ35715390-9CC215D0-11AD-4717-B644-CAAD495FF72CQ35827839-A413E617-B705-4369-874E-EBC8918192F3Q36018542-3B1B5AA8-DBFF-4AA2-8D4B-352F1430CFDAQ36171524-79477350-9C58-4714-951A-A28C63B904A4Q36221287-995831CE-F214-45FC-88FE-01719569BB75Q36238015-2602FC00-4D44-444B-ADEF-2AD5F06F8B36Q36442573-E0953156-09E2-457D-B997-7D34061FA3EDQ37026667-59EE8957-E73E-46C0-8A55-290C4DADB95BQ38019488-3733AC30-4AC1-4964-9CCA-CA8CB70E4F3AQ38386950-83BC9FEC-84E8-4554-ADD6-7AC0A151FB91Q38502294-91B34794-91CA-4ABB-AF56-4AA47C78DF1EQ38652464-62A0BD61-41B4-426C-8B84-4038FB526629Q42119482-5EBA96C3-4C1A-4FB7-BF1A-1066FA755206
P2860
Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Short-course chemotherapy with ...... latent tuberculosis infection.
@ast
Short-course chemotherapy with ...... latent tuberculosis infection.
@en
type
label
Short-course chemotherapy with ...... latent tuberculosis infection.
@ast
Short-course chemotherapy with ...... latent tuberculosis infection.
@en
prefLabel
Short-course chemotherapy with ...... latent tuberculosis infection.
@ast
Short-course chemotherapy with ...... latent tuberculosis infection.
@en
P2093
P2860
P921
P1476
Short-course chemotherapy with ...... latent tuberculosis infection.
@en
P2093
Eric L Nuermberger
Kathy N Williams
Koen Andries
Si-Yang Li
Tianyu Zhang
P2860
P304
P356
10.1164/RCCM.201103-0397OC
P407
P577
2011-06-09T00:00:00Z